Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Clinics ; 73: e184, 2018. tab, graf
Article in English | LILACS | ID: biblio-952804

ABSTRACT

OBJECTIVE: MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression at the posttranscriptional level. Some miRNAs, including let-7a and miR-195, have been described as tumor suppressors. However, the roles of these microRNAs in breast cancer progression remain controversial. The aim of this study is to evaluate miR-195 and let-7a expression as potential biomarkers of invasive breast cancer. METHODS: In the present study, 200 individuals were separated into three groups: (i) 72 women constituting the control group who were selected according to rigorous and well-established criteria; (ii) 56 patients with benign breast tumors; and (iii) 72 patients with malignant breast cancers of different clinical stages. The miR-195 and let-7a expression levels in serum were evaluated by real-time PCR. The results were assessed alone and in combination, and the analysis included an estimation of sensitivity and specificity in ROC curves. RESULTS: Compared with the benign and control groups, both microRNAs were downregulated in the malignant breast cancer patient group. Compared with the malignant group, the combination of both biomarkers in the control and benign groups showed good sensitivity and specificity in the serum with AUCs of 0.75 and 0.72, respectively. The biomarker combination for the control group versus the malignant group exhibited a better sensitivity and specificity than for the benign group versus the malignant group. CONCLUSION: These findings support the evidence that the analysis of miR-195 and let-7a can be used as a non-invasive biomarker for breast cancer detection.


Subject(s)
Breast Neoplasms/blood , MicroRNAs/blood , Reference Values , Breast Neoplasms/pathology , Biomarkers, Tumor/blood , Case-Control Studies , Down-Regulation , Gene Expression Regulation, Neoplastic , Logistic Models , Prospective Studies , Risk Factors , Analysis of Variance , Sensitivity and Specificity , Real-Time Polymerase Chain Reaction , Carcinogenesis/pathology , Neoplasm Invasiveness , Neoplasm Staging
2.
Endocrinology and Metabolism ; : 245-254, 2013.
Article in English | WPRIM | ID: wpr-141197

ABSTRACT

Pituitary tumors represent the most common intracranial neoplasms accompanying serious morbidity through mass effects and inappropriate secretion of pituitary hormones. Understanding the etiology of pituitary tumorigenesis will facilitate the development of satisfactory treatment for pituitary adenomas. Although the pathogenesis of pituitary adenomas is largely unknown, considerable evidence indicates that the pituitary tumorigenesis is a complex process involving multiple factors, including genetic and epigenetic changes. This review summarized the recent progress in the study of pituitary tumorigenesis, focusing on the role of tumor suppressor genes, oncogenes and microRNAs.


Subject(s)
Brain Neoplasms , Cell Cycle , Cell Transformation, Neoplastic , Epigenomics , Genes, Tumor Suppressor , MicroRNAs , Oncogenes , Pituitary Hormones , Pituitary Neoplasms
3.
Endocrinology and Metabolism ; : 245-254, 2013.
Article in English | WPRIM | ID: wpr-141196

ABSTRACT

Pituitary tumors represent the most common intracranial neoplasms accompanying serious morbidity through mass effects and inappropriate secretion of pituitary hormones. Understanding the etiology of pituitary tumorigenesis will facilitate the development of satisfactory treatment for pituitary adenomas. Although the pathogenesis of pituitary adenomas is largely unknown, considerable evidence indicates that the pituitary tumorigenesis is a complex process involving multiple factors, including genetic and epigenetic changes. This review summarized the recent progress in the study of pituitary tumorigenesis, focusing on the role of tumor suppressor genes, oncogenes and microRNAs.


Subject(s)
Brain Neoplasms , Cell Cycle , Cell Transformation, Neoplastic , Epigenomics , Genes, Tumor Suppressor , MicroRNAs , Oncogenes , Pituitary Hormones , Pituitary Neoplasms
4.
International Journal of Oral Biology ; : 179-185, 2011.
Article in Korean | WPRIM | ID: wpr-173973

ABSTRACT

MicroRNAs (miRNAs) are small non-coding RNAs that mediate gene expression at the post-transcriptional level by degrading or repressing targeted mRNAs. These molecules are about 21-25 nucleotides in length and exert their effects by binding to partially complementary sites in mRNAs, predominantly in the 3'-untranslated region (3'-UTR). Recent evidence has demonstrated that miRNAs can function as oncogenes or tumor suppressors through the modulation of multiple oncogenic cellular processes in cancer development, including initiation, cell proliferation, apoptosis, invasion and metastasis. In our present study, we examined the expression profile of miRNAs related to oral cancer cell growth inhibition using normal human oral keratinocytes (NHOK) and YD-38 human oral cancer cells. By miRNA microassay analysis, 40 and 31 miRNAs among the 1,769 examined were found to be up- and down-regulated in YD-38 cells compared with NHOK cells, respectively. Using qRT-PCR analysis, the expression levels of miR-30a and miR-1246 were found to be increased in YD-38 cells compared with NHOK cells, whereas miR-203 and miR-125a were observed to be decreased. Importantly, the overexpression of miR-203 and miR-125a significantly inhibited the growth of YD-38 cells. This finding and the microarray data indicate the involvement of specific miRNAs in the development and progression of oral cancer.


Subject(s)
Humans , Apoptosis , Cell Proliferation , Gene Expression , Keratinocytes , MicroRNAs , Mouth Neoplasms , Neoplasm Metastasis , Nucleotides , Oncogenes , RNA, Messenger , RNA, Small Untranslated
SELECTION OF CITATIONS
SEARCH DETAIL